UK renal registry 16th annual report: Chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: National and centre-specific analyses

Nephron - Clinical Practice

Volumn 125, Issue 1-4, 2014, Pages 183-208

  Rao, Anirudh ^a   Gilg, Julie ^a   Williams, Andrew ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; ANTIANEMIC AGENT;

ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NATIONAL HEALTH ORGANIZATION; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; REGISTER; RENAL REPLACEMENT THERAPY; UNITED KINGDOM; COHORT ANALYSIS; CONFERENCE PAPER; KIDNEY FUNCTION; SURVIVOR; ADOLESCENT; ADULT; AGED; BLOOD; COMPLICATION; FEMALE; HEALTH CARE MANAGEMENT; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; MIDDLE AGED; RESIDENTIAL CARE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANEMIA; ANNUAL REPORTS AS TOPIC; CATCHMENT AREA (HEALTH); ERYTHROPOIETIN; FEMALE; FERRITINS; GREAT BRITAIN; GUIDELINE ADHERENCE; HEMATINICS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERITONEAL DIALYSIS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RENAL DIALYSIS; YOUNG ADULT;

EID: 84896976229     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000360029     Document Type: Article

References (17)

1. KDIGO clinical practice guideline for anemia in chronic kidney disease. Summary of recommendations statements. Kidney International Supplements 2012;2:283-287
2. Department of Health Renal Team National Service Framework for Renal Services: Part One-Dialysis and transplantation, 2004, Department of Health: London
3. Renal Association. Treatment of adults and children with renal failure: standards and audit measures. 3rd Edition., 2002, Royal College of Physicians of London and the Renal Association: London
4. Locatelli F, et al. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrology Dialysis Transplantation 2009;24(2):348-354
5. National Institute for Health and Clinical Excellence (NICE). Anaemia management in people with chronic kidney disease (CG114), 2011
6. Renal Association Clinical Practice Guidelines Committee: Haemodialy-sis, 5th Edition. 2010. http://www.renal.org/clinical/guidelinessection/ haemodialysis.aspx
7. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney inter 2012:2(suppl 1);279-335
8. Movilli E, et al. Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. American journal of kidney diseases: the official journal of the National Kidney Foundation 2002:39(4);850-853
9. Kalantar-Zadeh K, et al. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. American Journal of Kidney Diseases 1995;26(2):292-299
10. Eschbach JW, et al. Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin. New England Journal of Medicine 1987:316(2);73-78
11. Singh AK, et al. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease. New England Journal of Medicine 2006:355(20);2085-2098
12. Drüeke TB, et al. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia. New England Journal of Medicine 2006:355(20):2071-2084
13. Pfeffer MA, et al. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. New England Journal of Medicine 2009: 361(21);2019-2032
14. Gomez-Alamillo C, et al. Erythropoietin Resistance as Surrogate Marker of Graft and Patient Survival in Renal Transplantation: 3-Year Prospective Multicenter Study. Transplantation Proceedings 2010; 42(8):2935-2937
15. Chung S, et al. Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis. Hemodialysis International 2012; 16(2):181-187
16. Panichi V, et al. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study. Nephrology Dialysis Transplantation, 2011;26(8): 2641-2648
17. Solomon SD, et al. Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes. New England Journal of Medicine 2010;363(12):1146-1155